Profile picture

Associate Professor Marie-Luce Bochaton-Piallat

University of Geneva, Geneva (Switzerland)
Membership: FESC Member
Follow
Biography
Marie-Luce Bochaton-Piallat, PhD (biochemistry), associate professor, leads a research group at the Faculty of Medicine at the University of Geneva where she also teaches cardiovascular pathophysiology. She is vice-chair of the Working Group Atherosclerosis and Vascular Biology of the ESC. She also serves as member of the scientific committee of the Swiss CardioVascular Biology Working Group and section editor of The ESC Textbook of Vascular Biology. Recently she co-edited a spotlight issue on Novel concept for the role of smooth muscle cells in vascular disease in CardioVascular Research. She has a longstanding experience in the implication of smooth muscle cell heterogeneity in atherosclerosis. She is currently investigating the role of S100A4 in the phenotypic modulation of intimal smooth muscle cells in vitro and in vivo. Since 2002 she receives continuous support from the Swiss National Science Foundation for her research. Her h-index is 34.
Logo ESC

Contributor content

Atherosclerosis: prevention and new regression
Session
Atherosclerosis: prevention and new regression
1 September 2025
Molecular drivers of vascular remodelling: from atherosclerosis to aneurysm therapy
Session
Molecular drivers of vascular remodelling: from atherosclerosis to aneurysm therapy
31 August 2025
What makes an atherosclerotic plaque vulnerable? novel perspectives
Session
What makes an atherosclerotic plaque vulnerable? novel perspectives
29 August 2025
Integrated therapeutic and regenerative strategies for myocardial infarction: from molecular pathways to novel repair approaches
Session
Integrated therapeutic and regenerative strategies for myocardial infarction: from molecular pathways to novel repair approaches
29 August 2025
Bed to bench and back: anti-vulnerable plaque strategies
Session
Bed to bench and back: anti-vulnerable plaque strategies
13 April 2024
Immunometabolic regulation of CVD
Session
Immunometabolic regulation of CVD
13 April 2024
Inflammatory mechanisms in vascular disease
Session
Inflammatory mechanisms in vascular disease
28 August 2023
Inflammation as key driver of vascular dysfunction
Session
Inflammation as key driver of vascular dysfunction
28 August 2023
Novel targets for treatment of atherosclerosis
Session
Novel targets for treatment of atherosclerosis
26 August 2023
Platelets in atherosclerosis and vascular biology: beyond thrombosis
Session
Platelets in atherosclerosis and vascular biology: beyond thrombosis
21 October 2022

ESC 365 is supported by